The SNP rs1050450 in GPX-1 as well as the SNP rs4880 in superoxide dismutase 2 (SOD-2), a related antioxidative enzyme that is not a selenoprotein, have been reported to modify the association of selenium exposure on cancer development, indicating that some individuals might be at higher risk than others [10,11]. This evidence concerns the gene SELENOS and cancer.